Explore acoustic-wave care.
Learn how branded SoftWave technology relates to shockwave therapy, what specific FDA clearances cover and which questions matter before a session.
Explore SoftWave therapy ↗
Search the website and the text of our downloadable patient guides.
REGENERATIVE MEDICINE, EXPLAINED
Understand the possibilities. Know the evidence. Make a choice that feels right for you.
Explore peptide medicines, PRP, cell-based therapies and emerging technology with patient-friendly explanations, trusted sources and practical next steps.
Good care starts with a good conversation.
Learning is your first step. A procedure is a separate decision.

EDUCATION GROUNDED IN
Sources you can examine.
NOW EXPLORE PEPTIDE MEDICINE
From established metabolic medicines to emerging recovery research, peptides deserve a complete conversation. Explore 27 named medicines and compounds, their evidence, risks and U.S. regulatory context.
Explore the peptide learning center ↗A CLOSER LOOK AT STEM CELL THERAPY
What makes a stem cell different? Why are some cell therapies established, while others are still being studied? Our expanded education center walks you through the answers.
Explore stem cell therapyUNDERSTAND THE OPTIONS
“Regenerative” describes a broad field, not one treatment. Start with the question that matters to you, then look at the evidence for your diagnosis.
PRP is prepared from your blood and concentrates platelets. It is being used and studied for selected joint and tendon conditions. It is not a stem-cell injection.
2026 AAPM&R guidance supports considering PRP for selected mild or moderate knee osteoarthritis after conservative care has not adequately helped. That does not mean it works for every painful joint.
Sources: [1] AAOS OrthoInfo, [2] AAPM&R
Read the PRP patient guide ↓What it may offerPotential symptom improvement for selected patients; results and protocols vary.
What is not establishedA promise to regrow arthritic cartilage or avoid surgery. A major knee trial found no significant advantage over saline at 12 months.
Not the same in every jointAAOS's July 2026 ankle guideline recommends against PRP for symptomatic ankle osteoarthritis.
Sources: [3] JAMA / University of Melbourne researchers, [4] American Association of Hip and Knee Surgeons, [5] American Academy of Orthopaedic Surgeons
A dermatologist can identify the cause of hair loss before a treatment is chosen. PRP may help selected patients; repeat care may be needed and improvement takes time.
Skin rejuvenation is a separate question. Evidence for PRP to reduce wrinkles or other signs of aging is limited.
Sources: [7] American Academy of Dermatology, [8] American Academy of Dermatology, [20] Johns Hopkins Medicine
Read the hair & skin guide ↓Ask about alternativesDepending on the diagnosis, options may include minoxidil, prescription care, transplantation or observation.
Measure fairlyAsk how progress will be documented and when the plan will be reassessed.
Know the tradeoffsDiscuss discomfort, bruising, infection risk, follow-up visits and total cost.
Sources: [7] American Academy of Dermatology, [20] Johns Hopkins Medicine
Stem cells can renew themselves and develop into specialized cells. That scientific potential does not prove that a particular injection repairs an arthritic joint.
FDA has approved specific cell products for specific uses, including Ryoncil and MACI. Approval of one product does not validate other products or other conditions.
Sources: [10] U.S. Food and Drug Administration, [11] U.S. Food and Drug Administration, [12] U.S. Food and Drug Administration, [21] National Institutes of Health
Ask for the exact productName, source, manufacturer, evidence and regulatory status should be clear.
Exosomes remain investigationalFDA's consumer alert states there are no FDA-approved exosome products. We do not recommend or advertise exosome treatment here.
Registration is not approvalA trial listing or registration number does not prove safety or effectiveness.
Sources: [9] U.S. Food and Drug Administration, [22] National Library of Medicine, [23] U.S. Food and Drug Administration
SoftWave is a branded acoustic-wave technology within the wider shockwave field. It applies pressure pulses through the skin and does not involve injecting stem cells or PRP. Device types and protocols vary.
Specific SoftWave musculoskeletal clearances include relief of minor muscle aches and pains, a temporary increase in local blood circulation, and activation of connective tissue. Those uses do not establish cartilage regrowth.
Sources: [30] U.S. Food and Drug Administration, [31] U.S. Food and Drug Administration, [18] NICE (United Kingdom), [19] NICE (United Kingdom)
Why this option?What diagnosis and clinical goal would this treatment address?
Which device and evidence?Ask which studies and U.S. regulatory status apply to that device and use. NICE is a UK guidance body.
What is the wider plan?Discuss rehabilitation, risks, visits, cost and what to do if it does not help.
These are educational topics. Individual suitability and RegenLuma service availability require confirmation.
A MORE COMPLETE CONVERSATION
Understand both the technology and the assessment behind a proposed care plan.
Learn how branded SoftWave technology relates to shockwave therapy, what specific FDA clearances cover and which questions matter before a session.
Explore SoftWave therapy ↗Understand common tests, why a clinician might order them and how results can inform an individual assessment.
Understand blood work ↗A SIMPLE VISUAL EXPLANATION
A simplified overview of a clinical process. The preparation, target and treatment plan vary; the diagram does not predict a result.
A small sample is taken from the patient.
The sample is spun to separate its components.
A platelet-rich portion is prepared for clinical use.
If appropriate, treatment and follow-up are tailored to the diagnosis.
THE EVIDENCE, IN CONTEXT
We look at recent guidance alongside important trials and safety information. Newer does not automatically mean better, and a promising result is not a guarantee.
AAPM&R's guidance considers patient selection, preparation and care context. Its suggestion about earlier intervention is expert consensus, not proof of an injection deadline.
Read AAPM&R's update ↗AAOS's new ankle guideline recommends against PRP for symptomatic ankle osteoarthritis. Good education includes evidence that challenges a treatment claim.
Read the AAOS guideline update ↗Recent FDA warnings reinforce why product identity, manufacturing controls and lawful regulatory status matter for human cell and tissue products.
Read the FDA patient warning ↗“No one treatment works for everyone”American Academy of Dermatology · Hair loss patient education [7]
That is why the right question is not simply “Does this work?” It is “What evidence applies to my condition, and what are my alternatives?”
Evidence checked October 21, 2026. Selected resources, not an exhaustive systematic review. Clinical review pending.
WHY TAKE THE NEXT STEP?
If symptoms keep limiting daily life, an evaluation can help you understand the cause and compare appropriate care. Learning and assessment can start now; a procedure should follow an informed decision.
Prepare for your conversation ↓Understand what is happening.Joint pain and hair loss can have different causes. Start with a diagnosis.
Review the complete care plan.Exercise, rehabilitation, medicines or other options may be more appropriate than a procedure.
Decide with confidence.Ask about realistic benefits, risks, cost, follow-up and the option of a second opinion.
Sources: [7] American Academy of Dermatology, [15] NIH / NIAMS, [16] National Library of Medicine / MedlinePlus
THE PATIENT LIBRARY
Eight free, printable guides to help you ask better questions. Each includes benefits, limitations, risks, alternatives and linked references. No email required.
Potential benefits, important limits, and questions worth asking.
Download PDF 4 pages · Free · No sign-upUnderstand the cause, set realistic expectations, and compare your options.
Download PDF 4 pages · Free · No sign-upSeparate scientific promise, approved products, and investigational claims.
Download PDF 4 pages · Free · No sign-upA noninvasive technology with condition-specific evidence.
Download PDF 4 pages · Free · No sign-upA practical guide to preparing for an informed medical conversation.
Download PDF 4 pages · Free · No sign-upUnderstand the technology, its cleared uses and the questions to ask.
Download PDF 4 pages · Free · No sign-upUnderstand what testing can tell you, what it cannot, and what comes next.
Download PDF 4 pages · Free · No sign-upExplore approved uses, emerging research, safety, blood work and questions for your clinician.
Download PDF 10 pages · Free · No sign-upWATCH & LEARN
Independent educational resources from Johns Hopkins Medicine. View them alongside the more recent guidance above; they are not endorsements of RegenLuma.
An introduction from a university health system. Specific uses require current, diagnosis-specific evidence.
Watch at the original source ↗Causes and treatments
for hair loss
Lisa Ishii, MD, discusses hair-loss causes and treatment choices for women and men.
View the official seminar page ↗Video loads only when you choose to play. YouTube or the source publisher may use its own cookies and privacy practices.
WHY REGENLUMA?
Our brand starts with a simple commitment: help people understand their choices before they make them.
We are developing RegenLuma around approachable education and respectful decision-making. As the clinic takes shape, we will publish confirmed provider qualifications, location, available services and consultation details.
See if you're a candidate ↗Original references, clear dates and honest explanations of what remains uncertain.
Benefits and risks alongside alternatives, including the choice not to have a procedure.
Questions welcomed. Costs, clinician qualifications and follow-up should be clear before treatment.
COMMON QUESTIONS
Do not assume so. AAHKS reports that biologic injections have not been shown to restore cartilage in osteoarthritic hips and knees. Specific approved cartilage-cell implants are different products with defined indications.
Sources: [4] American Association of Hip and Knee Surgeons, [12] U.S. Food and Drug Administration
No. PRP concentrates platelets from a blood sample. Cell-based products have different contents, preparation methods, evidence and regulatory requirements.
Sources: [1] AAOS OrthoInfo, [9] U.S. Food and Drug Administration
No. Clearance of equipment does not establish that every treatment performed with it is effective for every condition. Ask about the exact product, device and proposed use.
Sources: [4] American Association of Hip and Knee Surgeons, [9] U.S. Food and Drug Administration
Persistent or worsening symptoms deserve assessment. That does not establish a universal deadline for PRP, cells or shockwave. The right timing depends on the diagnosis, goals and options.
Sources: [15] NIH / NIAMS, [16] National Library of Medicine / MedlinePlus
This site is an educational introduction to a developing clinic brand. Confirmed treating clinicians, location, scheduling, pricing and available services will be published before treatment is offered. You can request general information below.
Seek prompt medical attention for a hot, red or markedly swollen joint with fever; inability to bear weight; obvious deformity; or severe symptoms after an injury. Do not wait for a reply to this site's contact form. For an emergency, call 911.
SEE IF YOU'RE A CANDIDATE
Take the first step by asking about the evaluation process. A qualified clinician must review your diagnosis, medical history, goals and alternatives before recommending a treatment.
This initial inquiry does not determine eligibility or confirm treatment availability. We will share confirmed clinician and consultation arrangements as RegenLuma develops.
Call RegenLuma1-800-595-PAIN1-800-595-7246Please do not send symptoms, diagnoses, medical records or insurance information. This form is for general information, not medical advice, emergencies or patient care.
Requests currently go to info@saferpros.com while RegenLuma's dedicated contact arrangements are established.